Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of a New Biomarker for Prostate Cancer Diagnosis

NCT01819740 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT01819740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01819740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of a New Biomarker for Prostate Cancer Diagnosis
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2013
Completion date
Not reported
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with suspected prostate cancer